Clinical trials
Completed Phase 2/3 trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 4 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Auckland, New Zealand | 3 |
| AbbVie | 2 |
| Amgen | 2 |
| AMO Pharma Limited | 1 |
| Abbott Medical Devices | 1 |
| Abivax S.A. | 1 |
| Ascendis Pharma Growth Disorders A/S | 1 |
| AstraZeneca | 1 |
| Australasian Gastro-Intestinal Trials Group | 1 |
| Australia and New Zealand Intensive Care Society | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Injuries, Traumatic | 2 |
| COVID-19 | 2 |
| Colitis, Ulcerative | 2 |
| Homozygous Familial Hypercholesterolemia | 2 |
| Hypercholesterolemia | 2 |
| Hyperlipoproteinemia Type II | 2 |
| Achondroplasia | 1 |
| Albuminuria | 1 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.